Rosen, trusted investor counsel, encourages regeneron pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action – regn

New york, jan. 22, 2025 (globe newswire) -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of regeneron pharmaceuticals, inc. (nasdaq: regn) between november 2, 2023 and october 30, 2024, both dates inclusive (the “class period”), of the important march 10, 2025 lead plaintiff deadline.
REGN Ratings Summary
REGN Quant Ranking